NCT05498272 · Interventional trial
Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations
Overall registry status Active not recruiting
Phase 2
Conditions BRCA1 Mutation, BRCA2 Mutation, High-Risk Cancer, Prostate Cancer, Prostatic Adenocarcinoma
Delaware Valley sites
- Penn Medicine Abramson Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory